Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare data
The economic burden of MCI was more than double that for similar individuals without MCI or dementia. Timely diagnosis and intervention are key to delaying progression to AD and reducing associated costs.
Authors
- Richard Batrla
- Soeren Mattke (ORCID: https://orcid.org/0000-0003-4666-9132)
- Feride Frech (ORCID: https://orcid.org/0000-0002-1992-1112)
- Susan De Santi (ORCID: https://orcid.org/0000-0002-1902-1202)
- Harald Hampel (ORCID: https://orcid.org/0000-0003-0894-8982)
- Timothy Juday (ORCID: https://orcid.org/0000-0002-7310-4113)
- Aaron S. Rosenberg (ORCID: https://orcid.org/0000-0003-0714-734X)
- Andrew Rava (ORCID: https://orcid.org/0000-0002-6740-4451)
- Colette Ndiba-Markey
- Gang Li (ORCID: https://orcid.org/0000-0001-8796-7510)
- Yingjie Ding
- Ara S. Khachaturian
Institutions
- University of Southern California (US)
- Alzheimer's Association (US)
- Epworth Hospital (AU)
- Prevent Alzheimer’s Disease 2020 (US)
- Genesis Medical Center (US)
- Eisai (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-07-24
- DOI
- https://doi.org/10.18553/jmcp.2025.31.8.782
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00